Inside GSK's Health Care Revolution

Nine years into her tenure as CEO of British pharmaceutical giant GlaxoSmithKline (GSK), Emma Walmsley is pressing forward on transforming health care. From discoveries in cancer drugs to new uses of AI in the field, the FTSE 100 CEO and No. 20 on Fortune’s 2025 Most Powerful Women ranking shares her outlook on the future of health care.